Global Bio-based Hemostatic Powder Market Growth 2026-2032
Description
The global Bio-based Hemostatic Powder market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Bio-based hemostatic powder is a hemostatic product made from natural biomaterials, designed to quickly control bleeding and promote wound healing. It is usually made of biomaterials such as plant extracts, chitosan, collagen, etc., and has good biocompatibility and degradability. Its working mechanism is to quickly stop bleeding by adsorbing blood, promoting platelet aggregation and accelerating blood clot formation. Bio-based hemostatic powder is widely used in trauma emergency treatment, surgery and other medical scenarios because its natural ingredients are friendly to the human body and can effectively reduce the risk of infection and complications.
United States market for Bio-based Hemostatic Powder is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Bio-based Hemostatic Powder is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Bio-based Hemostatic Powder is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Bio-based Hemostatic Powder players cover Johnson & Johnson, Medtronic, Baxter, BioCer Entwicklungs-GmbH, BD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Bio-based Hemostatic Powder Industry Forecast” looks at past sales and reviews total world Bio-based Hemostatic Powder sales in 2025, providing a comprehensive analysis by region and market sector of projected Bio-based Hemostatic Powder sales for 2026 through 2032. With Bio-based Hemostatic Powder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bio-based Hemostatic Powder industry.
This Insight Report provides a comprehensive analysis of the global Bio-based Hemostatic Powder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bio-based Hemostatic Powder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bio-based Hemostatic Powder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bio-based Hemostatic Powder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bio-based Hemostatic Powder.
This report presents a comprehensive overview, market shares, and growth opportunities of Bio-based Hemostatic Powder market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Oxidized Cellulose
Polysaccharides
Other
Segmentation by Application:
Surgery
First Aid
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Medtronic
Baxter
BioCer Entwicklungs-GmbH
BD
Hemostasis
MedTrade Products
Lanhine Medical
Haiyuan Hairun
Yancheng Yankang Medical Equipment
Success Bio-Tech
Beijing Aitekang Medical Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bio-based Hemostatic Powder market?
What factors are driving Bio-based Hemostatic Powder market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bio-based Hemostatic Powder market opportunities vary by end market size?
How does Bio-based Hemostatic Powder break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Bio-based hemostatic powder is a hemostatic product made from natural biomaterials, designed to quickly control bleeding and promote wound healing. It is usually made of biomaterials such as plant extracts, chitosan, collagen, etc., and has good biocompatibility and degradability. Its working mechanism is to quickly stop bleeding by adsorbing blood, promoting platelet aggregation and accelerating blood clot formation. Bio-based hemostatic powder is widely used in trauma emergency treatment, surgery and other medical scenarios because its natural ingredients are friendly to the human body and can effectively reduce the risk of infection and complications.
United States market for Bio-based Hemostatic Powder is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Bio-based Hemostatic Powder is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Bio-based Hemostatic Powder is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Bio-based Hemostatic Powder players cover Johnson & Johnson, Medtronic, Baxter, BioCer Entwicklungs-GmbH, BD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Bio-based Hemostatic Powder Industry Forecast” looks at past sales and reviews total world Bio-based Hemostatic Powder sales in 2025, providing a comprehensive analysis by region and market sector of projected Bio-based Hemostatic Powder sales for 2026 through 2032. With Bio-based Hemostatic Powder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bio-based Hemostatic Powder industry.
This Insight Report provides a comprehensive analysis of the global Bio-based Hemostatic Powder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bio-based Hemostatic Powder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bio-based Hemostatic Powder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bio-based Hemostatic Powder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bio-based Hemostatic Powder.
This report presents a comprehensive overview, market shares, and growth opportunities of Bio-based Hemostatic Powder market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Oxidized Cellulose
Polysaccharides
Other
Segmentation by Application:
Surgery
First Aid
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Medtronic
Baxter
BioCer Entwicklungs-GmbH
BD
Hemostasis
MedTrade Products
Lanhine Medical
Haiyuan Hairun
Yancheng Yankang Medical Equipment
Success Bio-Tech
Beijing Aitekang Medical Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bio-based Hemostatic Powder market?
What factors are driving Bio-based Hemostatic Powder market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bio-based Hemostatic Powder market opportunities vary by end market size?
How does Bio-based Hemostatic Powder break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
106 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Bio-based Hemostatic Powder by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Bio-based Hemostatic Powder by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
